Coronavirus, also known as COVID-19, is an infectious disease that causes severe respiratory-related illness. The review article from the Asian Pacific Journal of Allergy and Immunology suggests that it’s caused by the strain SARS-CoV-2 and this strain is known to have evolved from zoonotic betacoronavirus that infected animals. This evolved strain became a new human coronavirus, COVID-19, and started spreading worldwide. Although there are no vaccines available to treat the virus, there are antibody responses that are produced. IgM is the first antibody response produced during the first contact to an antigen. This antibody protects the body from the bloodstream infections and it helps to trigger the classical pathway of complement system activation. Another type of antibody, IgG provides long term protection of the body with the half-life of 21 days. This means half the number of IgG molecules will be reduced after 21 days. IgG is the first class of antibody produced during the secondary response. Another important aspect of this antibody is its ability to pass from mother to fetus through vertical transmission. Mother passes down the IgG antibodies to the fetus before the birth and they continue to pass down through breast milk.
Antibody titer is a laboratory test that depicts the presence and amount of antibodies in the blood. If the test is positive, the body has developed immunity. This means that antibodies were produced to fight off the antigens. The importance of having both IgM and IgG antibody is because IgM is released during primary response and IgG is released during secondary response. Having only the IgM means that it may fight of the antigen when it first encounters but if the same antigen is encountered later, there will be no antibodies released to fight off the antigen. Thus, it is crucial for presence of both IgM and IgG antibody. If we could determine an individual who was IgG positive with low or no IgM antibody, it will allow us to know that this individual may had infection sometime in the past. This also means that individual may carry the infection asymptomatically and infect others without knowing.
Relating back to antibody response in COVID-19, according to the review article from the Norwegian Institute of Public Health, one study showed that infants delivered by coronavirus infected mothers had increased levels of IgG and IgM levels with more infants having the increased IgG levels. In addition, the study shows that there is sustained IgG levels one year after the infection of coronavirus and the level persisted up to 13 years after the infection. Along with that, two studies averaged out the seroconversion timing for both IgM and IgG antibodies and it showed that timing ranged from 10-12 days and 12-14 days respectively. The preliminary study in the review article from APJAI also supports that one patient showed peak of IgM at day 9 after the onset of COVID-19 and switched to IgG by the second week. Another type of coronavirus, SARS-CoV, shares a good amount of its genetic material with COVID-19 and this infection induces long lasting specific IgG and neutralizing antibody in the body for up to 2 years after the infection. However, even though COVID-19 may be similar to SARS-CoV, there are no supporting researches that COVID-19 will activate same immune response in the body. Through this, one can learn that IgM and IgG response play a crucial role in fighting off the antigens. Moreover, tracing back the steps of antibody production and response allow tests to be done in determining whether or not someone was infected and if that person showed symptoms.


